Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Cited by (1,000)

Items 701–800 of 1,000

1. The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome‐related coronavirus‐2: A systematic review
   Bhanu Prasad Venkatesulu, Viveksandeep Thoguluva Chandrasekar, Prashanth Giridhar, V Pragathee, Harsh K. Patel, K Harsh, Jacob J. Manteuffel · 2020 · Journal of Medical Virology
2. Searching for COVID-19 treatments: First, do no harm
   Roy Guharoy, Edward P. Krenzelok · 2020 · American Journal of Health-System Pharmacy
3. Hydroxychloroquine And Azithromycin As A Treatment Of Covid- 19: Electrocardiogram Variability
   Amal El Ouarradi, Salma Abdeladim, Sara Oualim, Llham Bensahi, Sara Hafid, Hamza Tazi, Mahassine El Harras, Rita Aniq Filali, Abdelhamid Nailhou, El Arbi Bouaiti et al. · 2020 · Journal of the Saudi Heart Association
4. Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)
   Dmitry Evgenyevich Karateev, Е. Л. Лучихина · 2020 · Almanac of Clinical Medicine
5. Knowing More about Chloroquine/Hydroxycloroquine in COVID-19 Patients
   Antonio Cassone, Licia Iacoviello, Roberto Cauda · 2020 · Future Microbiology
6. Addressing Non-linear System Dynamics of Single-Strand RNA Virus–Host Interaction
   Alessandra Romano, Marco Casazza, Francesco Gonella · 2021 · Frontiers in Microbiology
7. Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York
   Eun Ji Kim, Kevin Coppa, Jamie S. Hirsch, Sara Abrahams, Jennifer Johnson, MARTIN L. LESSER, Karina W. Davidson, Joseph C. Conigliaro · 2021 · BMJ Open
8. Awake extracorporeal membrane oxygenation support for a critically ill COVID-19 patient: A case report
   Jing-Chen Zhang, Tong Li · 2021 · World Journal of Clinical Cases
9. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications
   Zhihan Wang, Kai Guo, Pan Gao, Qinqin Pu, Changlong Li, Junguk Hur, Min Wu · 2021 · Precision Clinical Medicine
10. Ethical challenges of prospective clinical trials during the COVID-19 pandemic
    Madison McCarthy, Matthew W. McCarthy · 2021 · Expert Review of Anti-infective Therapy
11. Ethical review of off-label drugs during the COVID-19 pandemic
    Qiuyu Li, Ye Lv, Zhuo‐Yu An, Ni-Ni Dai, Xue Hong, Yu Zhang, Li-Jun Liang · 2022 · World Journal of Clinical Cases
12. A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects
    Hitesh Kumar Dewangan, Akriti Rai, Kamal Shah, Rajiv Sharma · 2022 · Recent Patents on Nanotechnology
13. Novel triazole-nucleoside hybrids as potential antimicrobial agents: Design, synthesis, and molecular docking
    Mostafa E. Salem, Ibrahim Taha Radwan, Magdi E. A. Zaki, Arwa Sultan Alqahtani, Abdelfattah Selim, Mohammed H. Alruhaili, Hattan S. Gattan, Mohamed Abdel‐Megid, Noha M. Asaad Bagato, Ahmed H. M. Elwahy et al. · 2024 · Journal of Molecular Structure
14. Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
    Buğra Han Egeli, Jeffrey A. Sparks, Alfred H.J. Kim, Jean W. Liew · 2021 · Best Practice & Research Clinical Rheumatology
15. Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment
    Andrei Biţă, Ion Romulus Scorei, Laurenţiu Mogoantă, Cornelia Bejenaru, George Dan Mogoşanu, Ludovic Everard Bejenaru · 2020 · Romanian Journal of Morphology and Embryology
16. COVID 19: Resveratrol as a Potential Supplement to Mitigate the Cardiotoxicity Associated with Chloroquine and Hydroxychloroquine Treatment
    2020 · Biointerface Research in Applied Chemistry
17. COVID-19: Potential Repurposing Drugs
    Wattana Leowattana · 2021 · Infectious Disorders - Drug Targets
18. Editorial: COVID-19 and the quality use of medicines: evidence, risks and fads
    Darren M. Roberts, Alexandra A Bennett · 2020 · Australian Prescriber
19. Sequential ER stress and inflammatory responses are induced by SARS-CoV-2 ORF3 through ERphagy
    Xiaolin Zhang, Ziwei Yang, Xubing Long, Qinqin Sun, Fan Wang, Pei‐Hui Wang, Xiaojuan Li, Ersheng Kuang · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
20. Vaccination efforts in Brazil: scenarios and perspectives under a mathematical modeling approach
    THOMAS NOGUEIRA VILCHES, Felipe Alves Rubio, Rafael Augusto Forti Perroni, Gabriel Berg de Almeida, Carlos Magno Castelo Branco Fortaleza, Cláudia Pio Ferreira · 2021 · medRxiv
21. Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
    Alexis Lacout, Valère Lounnas, Christian Perronne · 2021 · International Journal of Antimicrobial Agents
22. Potential negative effects of the free use of chloroquine to manage COVID‐19 in Colombia
    Aníbal A. Teherán, Gabriel Camero, Carolina Hernández, Luis A. Pérez-García, Renato A. Guzmán, Alberto Paniz‐Mondolfi, Juan David Ramírez · 2020 · Journal of Medical Virology
23. Pharmacotherapy of Acute COVID-19 Infection and Multisystem Inflammatory Syndrome in Children: Current State of Knowledge
    Gladys M. El-Chaar · 2020 · Pediatric Allergy Immunology and Pulmonology
24. Character of hematological parameters change in patients with COVID-19
    V.I. Vechorko, Евсиков Евгений Михайлович, О. А. Байкова, Н. Н. Левчук · 2020 · Russian Journal of Preventive Medicine
25. Care of the Hepatology Patient in the COVID-19 Era
    Kathryn E. Driggers, Brett W. Sadowski, Eva Shagla, Ryan M. Kwok · 2022 · Current Hepatology Reports
26. Antimicrobial agents and torsades de pointes
    Kristen Bova Campbell · 2022 · Elsevier eBooks
27. Simultaneous quantification method for multiple antiviral drugs in serum using isotope dilution liquid chromatography–tandem mass spectrometry
    Nordiana Binti Rosli, Ha‐Jeong Kwon, Ji‐Seon Jeong · 2023 · Journal of Chromatography B
28. Organoids and Organ-On-Chip Models for COVID-19 Research and Its Application in Modernization of Traditional Chinese Medicine: Opportunities and Challenges
    Hongda Sheng, Yingxin Liang, Volker Martin Lauschke, Yi Wang · 2025 · Engineering
29. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19
    François Danion, Yvon Ruch, Marion Fourtage, Charlotte Kaeuffer, Valentin Greigert, Nicolas Lefèbvre, Joris Muller, Thierry Nai, Yves Hansmann · 2020 · Antimicrobial Agents and Chemotherapy
30. Eficacia y seguridad de cloroquina, hidroxicloroquina y azitromicina en pacientes con COVID-19: Resumen de evidencia
    Kelly Rocio Chacón Acevedo, Carlos Pinzón, Alexander Barrera, Eduardo Low Padilla, Nancy Yomayusa González · 2020 · Revista Colombiana de Nefrología
31. Characterising and managing paediatric SARSCoV‐2 infection: Learning about the virus in a global classroom
    Maria Camila Cardenas, Samyd Said Bustos, Elizabeth Ann L. Enninga, LYNNE M. MOFENSON, Rana Chakraborty · 2020 · Acta Paediatrica
32. The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time
    C. Hendricks, C. Herd, M. Nel, G. Tintinger, M. Pepper · 2021 · Frontiers in Medicine
33. One Year of the COVID‐19 Pandemic. What Do We Know and What Is Yet to Come? — The Summarising Review
    Wojciech Malchrzak, Agnieszka Mastalerz–Migas, Zbigniew Sroka, Maciej Spiegel · 2021 · International Journal of Public Health
34. Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
    Jamie Ngai, Madison Kalter, James Brian Byrd, Rebecca Racz, Yongqun Oliver He · 2022 · Frontiers in Pharmacology
35. COVID-19 Vaccination Outcomes and Antibiotic Crisis and Overuse During the COVID-19 Pandemic in Bosnia and Herzegovina
    Vedad Dedic, Armin Šljivo, Alen Arnautovic, Ahmed Mulać · 2022 · Materia Socio Medica
36. “Don’t Look Up” Your Science—Herd Immunity or Herd Mentality?
    Botond Z. Igyártó · 2022 · Microorganisms
37. Features of COVID-19 adult patients and the treatment in Indonesia: a retrospective cohort study
    Dwi Aris Agung Nugrahaningsih, Eko Purnomo, Siswanto Siswanto, Reviono Reviono, Alfi Yasmina, Muhammad Darwin Prenggono, Nanang Miftah Fajari, Mohammad Rudiansyah, Harsini, Rul Afiyah Syarif et al. · 2022 · Bali Medical Journal
38. Development of a multivariate model with desirability-based optimization for simultaneous determination of five co-administrated drugs for the management of COVID-19 infection in their dosage forms via validated RP-HPLC method
    Sonia Talaat Hassib, Marwa A. Moffid, Noha A. Aly, Eman A. Mostafa · 2022 · Journal of Liquid Chromatography & Related Technologies
39. Evidence-based pharmacotherapy in cardiology. National guideline
    S. Yu. Martsevich, Н. П. Кутишенко, Yu. V. Lukina, Vladimir V Yakusevich, Толпыгина Светлана Николаевна, Irina V. Samorodskaya, М. М. Lukyanov, A. V. Zagrebelny, Victoria A. Metelskaya, Поддубская Елена Александровна et al. · 2024 · Rational Pharmacotherapy in Cardiology
40. COVID‐19 research: an opinion piece
    Laura Jane Waters, Jürgen Kurt Rockstroh · 2020 · HIV Medicine
41. COVID-19 y arritmias: relación y riesgo
    Guillermo Mora · 2020 · Revista Colombiana de Cardiología
42. Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis
    Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, Tong Deng, Yun-Yun Wang, Xue-Qun Ren, Jianguang Ji et al. · 2020 · Frontiers in Pharmacology
43. COVID-19: Between Past and Present
    Areej M. Assaf, Randa N. Haddadin, Amal A. Akour · 2020 · Viral Immunology
44. Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report
    Francesco Vetta, Leonardo Marinaccio, Giampaolo Vetta, Domenico Marchese · 2020 · SAGE Open Medical Case Reports
45. Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries
    Varun U. Shetty, Brian Jason Brotherton, Andrew Achilleos, Kevan Akrami, Lia M. Barros, William Checkley, Natalie L. Cobb, Stephanie I. Maximous, David Misango, Casey Park et al. · 2020 · American Journal of Tropical Medicine and Hygiene
46. Chloroquine diphosphate suppresses liver cancer via inducing apoptosis in Wistar rats using interventional therapy
    Xiaoguang Hao, Weijing Li · 2021 · Oncology Letters
47. CLINICAL MANAGEMENT OF PATIENTS WITH COVID-19. “LIVE” CLINICAL INSTRUCTION (2021)
    Садов’як Ірина Дмитрівна · 2021 · ДЕРЖАВНА НАУКОВА УСТАНОВА «НАУКОВО-ПРАКТИЧНИЙ ЦЕНТР ПРОФІЛАКТИЧНОЇ І КЛІНІЧНОЇ МЕДИЦИНИ» eBooks
48. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase
    Diego Macías Saint-Gerons, Rafael Tabarés‐Seisdedos · 2021 · European Journal of Clinical Pharmacology
49. COVID-19 and Diabetes Mellitus: A Complex Interplay
    G. Koneru, Hager H. Sayed, Nayera A. Abd-elhamed, Nouran Elsedfy, A. Mohamed, Hania A. Abdellatif, Fatmaalzharaa F. Mohamed, Esraa H. Bahnasawy, N. Mousa, A. Eisa et al. · 2021 · Journal of Pure and Applied Microbiology
50. COVID-19: treatments and the potential for cardiotoxicity
    Sarah Maria Birkhoelzer, Elena Cowan, Kaushik Guha · 2021 · British Journal of Cardiology
51. Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019
    Michael Kevin Rooney, Eric G. Nesbit, Emma Brey Holliday, Reshma Jagsi, Clifton David Fuller, Ethan Bernard Ludmir, Sean Sachdev · 2021 · Advances in Radiation Oncology
52. COVID-19: The question of genetic diversity and therapeutic intervention approaches
    David Livingstone Alves Figueiredo, João Paulo Bianchi Ximenez, Fábio Rodrigues Ferreira Seiva, Carolina Panis, Rafael dos Santos Bezerra, Adriano Ferrasa, Alessandra Lourenço Cecchini, Alexandra Ivo de Medeiros, Ana Marisa Fusco‐Almeida, Anelisa Ramão et al. · 2021 · Genetics and Molecular Biology
53. Comparing of the First Electrocardiographic Variables in Patients with Newly Diagnosed COVID-19 with Healthy Men Volunteer: A Systematic Review and Meta-Analysis
    Mahdieh Arian, Ali Valinejadi, Farveh Vakilian · 2021 · Iranian Journal of Public Health
54. Therapeutic Agents Against COVID-19 with Clinical Evidence
    Cheng Tian, Ming Xiang · 2021 · Current Pharmaceutical Design
55. Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field
    Sasha Abdallah Fahme, Kathleen Frances Walsh, Vanessa Rouzier, Puja Chebrolu, Hyasinta Jaka, Justin R. Kingery, Fouad M. Fouad, Jyoti S. Mathad, Jennifer A. Downs, Margaret L. McNairy · 2021 · Family Medicine and Community Health
56. Drug-induced ‘Torsade de Pointes’ in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report
    Edimir Semedo, Gijsbert F.L. Kapel, Jurren M. van Opstal, Pascal F.H.M. van Dessel · 2020 · European Heart Journal - Case Reports
57. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19
    Yuli Guzmán-Prado · 2020 · The American Journal of Cardiology
58. Complementary Application of the Ozonized Saline Solution in Moderate and Severe Patients with Pneumonia Covid-19: Efficacy and Tolerability
    Adriana Schwartz, Gregorio Martı́nez-Sánchez, Alejandra Menassa de Lucía, Sergio Mejía Viana, Constanta Alina Mita · 2020 · Preprints.org
59. Development and progress of clinical trials of Coronavirus Disease 2019 antiviral drugs
    Wenyuan Pang, Qiaoyu Wang, Zhigang Zhao · 2020 · Expert Review of Clinical Pharmacology
60. Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient
    Tasnim I. Lat, Chhaya Patel, Jessica Ehrig, Conner Moslander, Juan F. Sanchez · 2020 · American Journal of Obstetrics & Gynecology MFM
61. Pharmacological treatment of COVID-19: an update
    Oyiyechukwu Onwudiwe, Homayemem K. Weli, Toluwanimi A Shaanu, Nkechi M Akata, Imoh L Ebong · 2020 · Journal of Global Health Reports
62. Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies
    Mohammad Khalid Parvez, Kartika Padhan · 2020 · Coronaviruses
63. Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19
    Stephani Correia Brazão, Lis Jappour Autran, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Fernanda Brito, Nadia Alice Vieira Motta · 2021 · International Journal of Cardiovascular Sciences
64. Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
    Seung‐Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, Ki‐Suk Kim · 2023 · Frontiers in Pharmacology
65. Promising medicinal plants as a starting point for clinical research into therapies for COVID-19: A literature review
    Lamiae Amallah, Rachida Hassikou, Basma Boukour, Allal Douira, Souad Skalli · 2024 · Ethnobotany Research and Applications
66. A Comprehensive Assessment of Environmental Implications, Ecotoxicity and Bioaccumulation Potential of Repurposed Drug Hydroxychloroquine: From Challenges to Sustainability
    Priyadarshini Gupta, Vibha Rani · 2024 · Reviews of Environmental Contamination and Toxicology
67. Tratamiento de COVID-19 en receptores de trasplante renal
    Luis Eduardo Morales-Buenrostro, Roxana Villca-Gonzales · 2020 · Revista Mexicana de Trasplantes
68. QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
    Sarah Grewal, Lior Jankelson, Marcel P. H. van den Broek, Martin Cour, Gloria Ann Bachmann, John B. Kostis, Kamana Misra · 2020 · Frontiers in Cardiovascular Medicine
69. Hydroxychloroquine for coronavirus: how not to repurpose a drug during a pandemic
    Harin Karunajeewa · 2020 · Internal Medicine Journal
70. Coronavirus Pandemic: Treatment and Future Prevention
    Kenneth H. Lundstrom · 2020 · Future Microbiology
71. COVID-19
    A. Ruckmani, K R Ilamathi, R. Arun Kumar, PM Umesh Kumar · 2020 · International journal of Nutrition Pharmacology Neurological Diseases
72. Safety and Efficacy of Hydroxychloroquine and Chloroquine in Treatment of COVID-19: A Rapid Review of Evidence
    Elham Khatooni, Farzan Berenjian, Zhaleh Abdi · 2021 · Health Technology Assessment in Action
73. A call to caution when hydroxychloroquine is given to elderly patients with COVID-19
    Julian Justin Gabor, Andrea Kreidenweiss, Stefan Weber, Moaaz Salama, Mihály Sulyok, Zita Sulyok, Erik Koehne, Meral Esen, Benno Kreuels, Parichehr Shamsrizi et al. · 2021 · International Journal of Infectious Diseases
74. Impact of Coronavirus Diseases on Liver Enzymes
    Ammara Naeem, Manoj Kumar Khamuani, Pardeep Kumar, FNU Pooja, Deepak Raj, Kirshan Lal, Wajeeha Shahid, Waseem Mahar, Amber Rizwan, Aliya Fatima · 2021 · Cureus
75. Novel and promising approaches in COVID-19 treatment
    Zahra Asefy, Hamid Rashidzadeh, Ali MOHAMMADI, Mohammad Charehsaz · 2021 · Journal of Research in Pharmacy
76. Case Report: Use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 positive patient
    Carlos A. Puyo, Danielle Kreig, Venugopal Saddi, Essam Ansari, Oliver A. Prince · 2020 · F1000Research
77. Prognosis of COVID-19 in respiratory allergy: a systematic review and meta-analysis
    Alia A. El Shahaway, Kelechi Elizabeth Oladimeji, Aboalmagd Hamdallah, Amal Saidani, Rami Abd‐Rabu, Nesrine Ben Hadj Dahman · 2022 · Egyptian Journal of Bronchology
78. COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases
    Norman A. Ratcliffe, Helena Carla Castro, Izabel Christina Nunes de Palmer Paixão, Cicero Brasileiro de Mello Neto · 2020 · Current Medicinal Chemistry
79. COVID-19 and Arrhythmias: A Review of Cardiac Electrophysiology Associated with SARS-CoV-2
    Kashmala Khan, Francis Dimtri, Carlos Vargas, Thomas Alexander · 2020 · HCA Healthcare Journal of Medicine
80. Taking a stand against the politicization of medical research: how ‘swinging the pendulum’ poses a hazard to clinical trials, study participants, and the progress of science
    Anna Bershteyn, Mark D. Schwartz, Lorna E. Thorpe, Michael K. Paasche‐Orlow, PATRICIA J. KISSINGER, Helen C. Stankiewicz Karita, Miriam K. Laufer, Risa M. Hoffman, Raphael J. Landovitz, Kristopher M. Paolino et al. · 2020 · Expert Review of Clinical Immunology
81. Reticulophagy Reprograms the Endoplasmic Reticulum for SARS-CoV-2 Replication
    Xiaojuan Li, Ersheng Kuang · 2022 · Frontiers in Cell and Developmental Biology
82. Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
    Estefanía Calvo Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante et al. · 2022 · Microorganisms
83. COVID‐19: From pathogenesis models to the first drug trials
    Harald Brüssow · 2020 · Microbial Biotechnology
84. AMB Guidelines: COVID -19.
    Lincoln Lopes Ferreira, Diogo Leite Sampaio, A. Chagas, H. Guimarães, L. Hajjar, S. Lobo, C. Abdo, José Luiz Bonamigo, H. Bacha, Robson Freitas de Moura et al. · 2020 · Revista da Associação Médica Brasileira
85. COVID-19;-The origin, genetics,and management of the infection of mothers and babies
    Hassan I. El‐Sayyad, Yousef K. A. Abdalhafid · 2020 · Egyptian Journal of Basic and Applied Sciences
86. Response to: ‘Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al
    Elizabeth R. Graef, Jean W. Liew, Alfred H.J. Kim, Jeffrey A. Sparks · 2020 · Annals of the Rheumatic Diseases
87. Safety profile of chloroquine and hydroxychloroquine: an analysis of the FDA Adverse Event Reporting System (FAERS) database
    Georgios Papazisis, Spyridon Siafis, Dainora Cepaityte, Dimitrios Giannis, Dimitrios Tzachanis, Toine C. G. Egberts · 2020
88. How likely are COVID-19 interventions to benefit the sickest patients?
    Anders Perner, Bharath Kumar Tirupakuzhi Vijayaraghavan, Balasubramanian Venkatesh · 2020 · Intensive Care Medicine
89. Risk factors associated with implant sites prepared by orthodontic treatment: a systematic review
    Taban, Mohsen, Fatemi, Arezousadat, Soleimani, Milad, Sajedi, Seyed Masoud, Sabzevari, Berahman · 2023 · European Journal of Translational Myology
90. Seven day continuous ambulatory electrocardiographic telemetric study with pocket electrocardiographic recording device for detecting hydroxychloroquine induced arrhythmias
    Rohit Walia, Nanda Prabhakaran, Ashwin Kodliwadmath, O Budha Charan Singh, Vikas Sabbarwal, Abhimanyu Nigam, Kartik Vijay B, Venkatesh S Pai · 2022 · Journal of Family Medicine and Primary Care
91. Clinical features and inflammatory signatures of patients with persistent gastrointestinal long COVID two years after severe SARS-CoV-2 infection
    Arlene dos Santos PINTO, Victor Irungu Mwangi, Juliana Costa Ferreira Neves, Alex Bezerra da Silva Maciel, Alexandre Vilhena da Silva Neto, Jefferson da Silva Valente, Gisely Cardoso de Melo, Wuelton Marcelo Monteiro, Vanderson de Souza Sampaio, Allyson Guimarães Costa et al. · 2026 · Scientific Reports
92. COVID-19 Prevalence and Outcomes among Individuals with Rheumatoid Arthritis and Systemic Lupus Erythematosus Taking Hydroxychloroquine; A Retrospective Analysis
    Arash Mollaeian, Daniel S. Kim, Christopher James Haas · 2021 · The Open Rheumatology Journal
93. Outpatient medications associated with protection from COVID-19 hospitalization
    Harpal Singh Sandhu, Joshua Lambert, Zachary Steckler, Lee Park, Arnold J. Stromberg, Julio A. Ramírez, Chi‐Fu Jeffrey Yang · 2023 · PLoS ONE
94. Translatability scoring in prospective and retrospective COVID drug development cases
    Alexandra Wendler, Martin Wehling · 2023 · European Journal of Clinical Pharmacology
95. Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020
    Latifa Aït Moussa, Amina Tebaa, Loubna Alj, Houda Sefiani, Fatima Zahra Meskı, Asmae Khattabi, Rachida Soulaymani Bencheikh · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
96. Amino Acid Metabolism in Leukocytes Showing In Vitro IgG Memory from SARS-CoV2-Infected Patients
    Giuseppina Fanelli, Veronica Lelli, Sara Rinalducci, Anna Maria Timperio · 2024 · Diseases
97. Drug–Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study
    Caterina Trevisan, Andrea Cignarella, Andrea Grandieri, Giuseppe Sergi, Stefano Fumagalli, Fabio Monzani, Chukwuma Okoye, Giuseppe Bellelli, Alba Malara, Pietro Gareri et al. · 2024 · Reports — Medical Cases Images and Videos
98. Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19
    Yunlong Jia, Wenjie Tian, Yuyao Li, Yuyan Teng, Xiaolin Liu, Zhengyu Li, Mingsheng Zhao · 2024 · Heliyon
99. A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories
    João Luiz Silva‐Filho, Vanessa Herder, Matthew P. Gibbins, Monique Freire Santana, Gisely Cardoso de Melo, Michael Haley, Carla C. Judice, Fernando Val, Mayla Gabriela Silva Borba, Tatyana Almeida Tavella et al. · 2024 · Science Translational Medicine
100. COVID-19 vaccine safety and effectiveness at 3 months in institutionalized old people
     Mathilde Malignac, A. Besseiche, Anaïs Cloppet-Fontaine, Mohand Ouali Sadeg, J. Jafarbay, Mathilde Gourdon, Christophe Trivalle, Claude Jeandel, Jean‐Sébastien Vidal, Olivier Hanon et al. · 2024 · BMC Geriatrics